Ji, G.; Guo, Q.; Xue, Q.; Kong, R.; Wang, S.; Lei, K.; Liu, R.; Wang, X.
Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. Molecules 2021, 26, 6907.
https://doi.org/10.3390/molecules26226907
AMA Style
Ji G, Guo Q, Xue Q, Kong R, Wang S, Lei K, Liu R, Wang X.
Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. Molecules. 2021; 26(22):6907.
https://doi.org/10.3390/molecules26226907
Chicago/Turabian Style
Ji, Guoxia, Qinghua Guo, Qidi Xue, Ruifang Kong, Shiben Wang, Kang Lei, Renmin Liu, and Xuekun Wang.
2021. "Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes" Molecules 26, no. 22: 6907.
https://doi.org/10.3390/molecules26226907
APA Style
Ji, G., Guo, Q., Xue, Q., Kong, R., Wang, S., Lei, K., Liu, R., & Wang, X.
(2021). Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. Molecules, 26(22), 6907.
https://doi.org/10.3390/molecules26226907